The Role of Complement in Transfusion-Related Acute Lung Injury.

Authors:
Jongerius I; Porcelijn L; van Beek AE; Semple JW; van der Schoot CE and 2 more

Journal:
Transfus Med Rev

Publication Year: 2019

DOI:
10.1016/j.tmrv.2019.09.002

PMCID:
PMC7127679

PMID:
31676221

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Transfus Med Rev

Abbreviation: Transfus Med Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2.
Burnouf T; Gathof B; Bloch EM and 11 more (2022) - Transparency Score: 3/6
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Framework for…
Liao G; Zheng K; Lalu MM and 2 more (2020) - Transparency Score: 2/6
A Scoping Review of Registered Clinical Trials of Convalescent Plasma for COVID-19 and a Framework …
Zheng K; Liao G; Lalu MM and 3 more (2020) - Transparency Score: 1/6
Convalescent Plasma: Therapeutic Hope or Hopeless Strategy in the SARS-CoV-2 Pandemic.
Sullivan HC; Roback JD. (2020) - Transparency Score: 1/6
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection.
Murphy M; Estcourt L; Grant-Casey J and 1 more (2020) - Transparency Score: 1/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest None."

Evidence found in paper:

"AcknowledgmentsThis work was supported by Sanquin (grant PPOC-18-08)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025